Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma

Head and Neck

Volumn 38, Issue , 2016, Pages E1068-E1074

  Rachidi, Saleh ^a,b   Wallace, Kristin ^a,b   Wrangle, John M ^a   Day, Terry A ^a,b   Alberg, Anthony J ^a,b   Li, Zihai ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cancer; head; lymphocyte; neck; neutrophil

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; WART VIRUS; AGED; CYTOLOGY; DISEASE FREE SURVIVAL; HEAD AND NECK TUMOR; LYMPHOCYTE; NEUTROPHIL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84945531748     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24159     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Choi SY, Kahyo H,. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 1991; 20: 878-885.
3. Gillison ML, Koch WM, Capone RB, et al., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
4. Woolgar JA,. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2006; 42: 229-239.
5. Bernier J, Cooper JS, Pajak TF, et al., Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005; 27: 843-850.
6. Grivennikov SI, Greten FR, Karin M,. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
7. Gabrilovich DI, Nagaraj S,. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
8. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW,. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60: 1419-1430.
9. Balermpas P, Michel Y, Wagenblast J, et al., Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 2014; 110: 501-509.
10. Trellakis S, Bruderek K, Dumitru CA, et al., Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011; 129: 2183-2193.
11. Dumitru CA, Fechner MK, Hoffmann TK, Lang S, Brandau S,. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. J Leukoc Biol 2012; 91: 591-598.
12. Wu WC, Sun HW, Chen HT, et al., Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A 2014; 111: 4221-4226.
13. Li J, Jiang R, Liu WS, et al., A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One 2013; 8: e83069.
14. He JR, Shen GP, Ren ZF, et al., Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012; 34: 1769-1776.
15. Fang HY, Huang XY, Chien HT, et al., Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope 2013; 123: 2690-2699.
16. Perisanidis C, Kornek G, Pöschl PW, et al., High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013; 30: 334.
17. Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG,. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck 2015; 37: 103-110.
18. Tsai YD, Wang CP, Chen CY, et al., Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 2014; 36: 947-953.
19. Azab B, Camacho-Rivera M, Taioli E,. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 2014; 9: e112361.
20. Dale DC, Fauci AS, Guerry DI, Wolff SM,. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 1975; 56: 808-813.
21. Goldstein MG, Li Z,. Heat-shock proteins in infection-mediated inflammation-induced tumorigenesis. J Hematol Oncol 2009; 2: 5.
22. Okazaki IM, Kotani A, Honjo T,. Role of AID in tumorigenesis. Adv Immunol 2007; 94: 245-273.
23. Oguma K, Oshima H, Aoki M, et al., Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 2008; 27: 1671-1681.
24. Grivennikov SI, Karin M,. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010; 21: 11-19.
25. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M,. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010; 17: 89-97.
26. Aharinejad S, Abraham D, Paulus P, et al., Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res 2002; 62: 5317-5324.
27. Lin EY, Nguyen AV, Russell RG, Pollard JW,. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 727-740.
28. Morales C, Rachidi S, Hong F, et al., Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis. Cancer Res 2014; 74: 446-459.
29. Marabelle A, Kohrt H, Sagiv-Barfi I, et al., Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest 2013; 123: 2447-2463.
30. Curiel TJ, Coukos G, Zou L, et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
31. Bates GJ, Fox SB, Han C, et al., Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24: 5373-5380.
32. Kobayashi N, Hiraoka N, Yamagami W, et al., FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007; 13: 902-911.
33. Overwijk WW, Theoret MR, Finkelstein SE, et al., Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 2003; 198: 569-580.
34. Klebanoff CA, Gattinoni L, Torabi-Parizi P, et al., Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 2005; 102: 9571-9576.
35. Xie Y, Akpinarli A, Maris C, et al., Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 2010; 207: 651-667.
36. Tran E, Turcotte S, Gros A, et al., Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 2014; 344: 641-645.